In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Angiotech and Orthovita in biomaterials deal

Executive Summary

Orthovita (orthopedic biomaterials) will be the exclusive N. American marketer for Angiotech Pharmaceuticals' (coatings and biomaterials) CoStasis liquid surgical hemostat gel that controls bleeding and promotes soft tissue healing. The companies will take equal shares of the operating profits and Angiotech's subsidiary Cohesion Technologies will handle manufacturing.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Marketing
    • Includes Contract
    • Includes Equity
    • Intra-Biotech Deal
    • Marketing (Licensing)

Related Companies